J Liao, X Li, Y Gan, S Han, P Rong, W Wang… - Frontiers in …, 2023 - frontiersin.org
Cancer is a major medical problem worldwide. Due to its high heterogeneity, the use of the same drugs or surgical methods in patients with the same tumor may have different curative …
Inter and intra-tumoral heterogeneity are major stumbling blocks in the treatment of cancer and are responsible for imparting differential drug responses in cancer patients. Recently …
L Wang, Y Song, H Wang, X Zhang, M Wang, J He… - Pharmaceuticals, 2023 - mdpi.com
Anti-cancer drug design has been acknowledged as a complicated, expensive, time- consuming, and challenging task. How to reduce the research costs and speed up the …
M Kureljusic, E Karger - Journal of Applied Accounting Research, 2023 - emerald.com
Purpose Accounting information systems are mainly rule-based, and data are usually available and well-structured. However, many accounting systems are yet to catch up with …
X Liu, C Song, F Huang, H Fu, W Xiao… - Briefings in …, 2022 - academic.oup.com
Predicting the response of a cancer cell line to a therapeutic drug is an important topic in modern oncology that can help personalized treatment for cancers. Although numerous …
Phosphorylation is one of the quickest post-translational modifications that controls downstream signaling pathways regulating processes like cell proliferation, survival, and …
P Zhang, S Tu, W Zhang, L Xu - Briefings in Bioinformatics, 2022 - academic.oup.com
Identifying synergistic drug combinations (SDCs) is a great challenge due to the combinatorial complexity and the fact that SDC is cell line specific. The existing …
To enable personalized cancer treatment, machine learning models have been developed to predict drug response as a function of tumor and drug features. However, most algorithm …
Our understanding of the molecular mechanisms underlying cancer development and evolution have evolved rapidly over recent years, and the variation from one patient to …